Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Selicrelumab by F. Hoffmann-La Roche for Head And Neck Squamous Cell Carcinoma (HNSC): Likelihood of Approval
Selicrelumab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Head And Neck Squamous Cell...